IndiaTickerLatest filing: Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
ObservedCompany dossier
Strides Pharma Science
NSE:STAR · ISIN INE939A01011
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Strides Pharma Science
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹1,153.7 Cr · PAT ₹90 Cr.
Exchange XBRLLatest ownership: promoter group 27.91% and public 72.09% as of 30 Jun 2026.
Exchange XBRLLatest rating action: Strides Pharma Science Limited
Archived reportMaterial events
Open timeline →What changed recently
Observed
Source filing Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE · conference call
Observed
Source filing Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recording
BSE · conference call recording
Observed
Source filing Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · financial results
Observed
Source filing Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE · conference call
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹1,153.7 Cr
- Profit after tax
- ₹90 Cr
- EPS
- ₹9.56
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 27.91%
- Public
- 72.09%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL